Overexpression of clusterin correlates with tumor progression, metastasis in gastric cancer: a study on tissue microarrays
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Clusterin (CLU) is expressed in a wide variety of human tissues and fluids. Overexpression of cytoplasmic clusterin (sCLU) has been implicated in cancer development and progression. The aim of the present study is to evaluate the association of sCLU overexpression with clinicopathological features of human gastric carcinomas (GC).We constructed a gastric cancer tissue microarray containing 173 primary gastric carcinomas and 70 paired non-neoplastic mucosa specimens. The expression of sCLU was studied by immunohistochemistry. The correlations between sCLU expression and clinicopathological features, p53 abnormality, as well as Ki67 activation were analyzed. Overexpressions of sCLU was detected in 28.5% (n=165) of primary GCs by immunohistochemical staining, but not in non-neoplastic mucosa. Clinical association study found that overexpression of sCLU was significantly correlated with lymph-node metastasis (p < 0.001), tumor invasion (p < 0.001) and TNM stage (p < 0.001). In Kaplan-Meier survival analysis, overexpression of sCLU was significantly correlated with unfavorable survival in advanced GCs (p < 0.03). Furthermore, the association of sCLU with abnormal expression of p53 was ascertained. These results suggested that overexpression of sCLU was involved in the progression of GC and it's oncogenic function might be associated with p53 abnormality. Overexpression of sCLU seems to be related with patient's shorter survival in late stage GC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clusterin inhibits apoptosis by interacting with activated Bax
Zhang, H., Kim, J. K., Edwards, C. A., Xu, Z., Taichman, R., & Wang, C.-Y. (2005) · Nature Cell Biology · doi:10.1038/ncb1291 · Cited by 453 · cited 1×
“Elevated sCLU levels could enhance tumorigenesis by interfering with Bax proapoptotic activities [30].”
BackgroundTrougakos, I. P., Lourda, M., Antonelou, M. H., Kletsas, D., Gorgoulis, V. G., Papassideri, I. S., Zou, Y., Margaritis, L. H., Boothman, D. A., & Gonos, E. S. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1805 · Cited by 160
Cited by
Carlage, T., Kshirsagar, R., Zang, L., Janakiraman, V., Hincapie, M., Lyubarskaya, Y., Weiskopf, A., & Hancock, W. S. (2012) · Biotechnology Progress · doi:10.1002/btpr.1534 · Cited by 38
Jeon, Y. K., Kim, S. S., Kim, J. H., Kim, H. J., Kim, H. J., Park, J. J., Cho, Y. S., Joung, S. H., Kim, J. R., Kim, B. H., et al. (2020) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2018.0160 · Cited by 34
Wang, Q., Cao, W., Su, Q., Liu, Z., & Zhang, L. (2014) · World Journal of Surgical Oncology · doi:10.1186/1477-7819-12-124 · Cited by 14
Self-citationdos Santos, E. C., Rohan, P., Binato, R., & Abdelhay, E. (2023) · Cancers · doi:10.3390/cancers15225374 · Cited by 3
“In accordance with our results, hsa-miR-195-5p expression was significantly downregulated in the tissues and serum of GC patients [42]. hsa-miR-195-5p is related to regulation of the Wnt/ β -catenin pathway [42], the epithelial-to-mesenchymal transition [43], and multidrug resistance [44,45].”
Result
Metadata
- Authors
- Bi, J., Guo, A., Lai, R., Li, B., Zhong, J., Wu, H., Xie, Z., He, L., Lv, L., Lau, S., Wang, Q., Huang, X., Zhang, L., Wen, J., & Guan, Y.
- Venue
- Neoplasma
- Publisher
- AEPress, s.r.o.
- Published
- 2010
- Volume
- 57
- Issue
- 3
- Pages
- 191-197
- ISSN
- 0028-2685 (ISSN-L)
- OpenAlex
- W2057992597
- Cited by
- 48
- References
- 2
- FWCI
- 3.70
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.